EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 0.0554
March 31, 2026 -0.1762
December 31, 2025 0.1082
September 30, 2025 0.0331
June 30, 2025 -0.1405
March 31, 2025 -0.1753
December 31, 2024 0.0186
September 30, 2024 -0.114
June 30, 2024 -0.038
March 31, 2024 -0.1956
December 31, 2023 -0.157
September 30, 2023 -0.0691
June 30, 2023 -0.0754
March 31, 2023 -0.087
December 31, 2022 -0.1404
September 30, 2022 -0.089
June 30, 2022 -0.2512
March 31, 2022 -0.2276
December 31, 2021 -0.1939
September 30, 2021 -0.3167
June 30, 2021 -0.1525
March 31, 2021 -0.1877
December 31, 2020 -0.2778
Date Value
September 30, 2020 -0.2575
June 30, 2020 -0.2436
March 31, 2020 -0.2259
December 31, 2019 -0.3267
September 30, 2019 -0.1863
June 30, 2019 -0.1908
March 31, 2019 -0.1726
December 31, 2018 -0.187
September 30, 2018 -0.1339
June 30, 2018 -0.5153
March 31, 2018 -0.1038
December 31, 2017 -0.1046
September 30, 2017 -0.1686
June 30, 2017 0.0382
March 31, 2017 -0.1127
December 31, 2016 -0.0738
September 30, 2016 -0.1088
June 30, 2016 -0.1181
March 31, 2016 -0.4553
December 31, 2015 -0.0762
September 30, 2015 -0.0332
June 30, 2015 -0.0417
March 31, 2015 -0.0603

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 0.0141
GNI Group Ltd. 0.0156
AnGes, Inc. -0.0258
ACADIA Pharmaceuticals, Inc. 0.1822
Alkermes Plc 0.0029